Evaluation of the Cytotoxicity of Ayahuasca Beverages
Overview
Authors
Affiliations
Ayahuasca is a beverage consumed at shamanic ceremonies and currently has gained popularity on recreational scenarios. It contains beta-carboline alkaloids and ,-dimethyltryptamine, which possesses hallucinogenic effects. Only a few studies have elicited the psychoactive effects and the dose of such compounds on neurological dopaminergic cells or animals. In this work, we aimed to study the cytotoxic effects of these compounds present in ayahuasca beverages and on five different teas (, , , and Dc Ab (commercial name)) preparations on dopaminergic immortalized cell lines. Moreover, a characterization of the derivative alkaloids was also performed. All the extracts were characterized by chromatographic systems and the effect of those compounds in cell viability and total protein levels were analyzed in N27 dopaminergic neurons cell line. This is the first article where cytotoxicity of ayahuasca tea is studied on neurological dopaminergic cells. Overall, results showed that both cell viability and protein contents decreased when cells were exposed to the individual compounds, as well as to the teas and to the two mixtures based on the traditional ayahuasca beverages.
Larit F, Leon F Plants (Basel). 2023; 12(22).
PMID: 38005756 PMC: 10674704. DOI: 10.3390/plants12223860.
A Systematic Review on the Therapeutic Effects of Ayahuasca.
Goncalves J, Luis A, Gallardo E, Duarte A Plants (Basel). 2023; 12(13).
PMID: 37447135 PMC: 10346174. DOI: 10.3390/plants12132573.
Evaluation of the In Vitro Wound-Healing Potential of Ayahuasca.
Goncalves J, Luis A, Gallardo E, Duarte A Molecules. 2022; 27(18).
PMID: 36144509 PMC: 9505110. DOI: 10.3390/molecules27185760.
Characterisation of the Phenolic Profile of and Flowers' Extracts.
Pedro S, Rosado T, Barroca C, Neiva D, Alonso-Herranz V, Gradillas A Plants (Basel). 2022; 11(11).
PMID: 35684215 PMC: 9182983. DOI: 10.3390/plants11111442.
Therapeutic Properties of Ayahuasca Components in Ischemia/Reperfusion Injury of the Eye.
Szilagyi A, Takacs B, Szekeres R, Tarjanyi V, Bombicz M, Priksz D Biomedicines. 2022; 10(5).
PMID: 35625734 PMC: 9138933. DOI: 10.3390/biomedicines10050997.